These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30185421)

  • 1. A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment.
    Henderson MC; Silver M; Tran Q; Letsios EE; Mulpuri R; Reese DE; Lourenco AP; LaBaer J; Anderson KS; Alpers J; Costantini C; Rohatgi N; Ali H; Baker K; Northfelt DW; Ghosh K; Grobmyer SR; Polen W; Wolf JK
    Clin Cancer Res; 2019 Jan; 25(1):142-149. PubMed ID: 30185421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years.
    Lourenco AP; Benson KL; Henderson MC; Silver M; Letsios E; Tran Q; Gordon KJ; Borman S; Corn C; Mulpuri R; Smith W; Alpers J; Costantini C; Rohatgi N; Yang R; Haythem A; Biren S; Morris M; Kass F; Reese DE
    Clin Breast Cancer; 2017 Nov; 17(7):516-525.e6. PubMed ID: 28624156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast density does not impact the ability of Videssa® Breast to detect breast cancer in women under age 50.
    Reese DE; Henderson MC; Silver M; Mulpuri R; Letsios E; Tran Q; Wolf JK
    PLoS One; 2017; 12(10):e0186198. PubMed ID: 29069101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
    Fredolini C; Pathak KV; Paris L; Chapple KM; Tsantilas KA; Rosenow M; Tegeler TJ; Garcia-Mansfield K; Tamburro D; Zhou W; Russo P; Massarut S; Facchiano F; Belluco C; De Maria R; Garaci E; Liotta L; Petricoin EF; Pirrotte P
    Breast Cancer Res; 2020 Dec; 22(1):135. PubMed ID: 33267867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-negative rate of combined mammography and ultrasound for women with palpable breast masses.
    Chan CH; Coopey SB; Freer PE; Hughes KS
    Breast Cancer Res Treat; 2015 Oct; 153(3):699-702. PubMed ID: 26341750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
    Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
    Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
    Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
    Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic mammography and sonography: concordance of the breast imaging reporting assessments and final clinical outcome].
    Lorenzen J; Wedel AK; Lisboa BW; Löning T; Adam G
    Rofo; 2005 Nov; 177(11):1545-51. PubMed ID: 16302136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Mammography Abnormality Features to Genetic Variants in the Prediction of Breast Cancer in Women Recommended for Breast Biopsy.
    Burnside ES; Liu J; Wu Y; Onitilo AA; McCarty CA; Page CD; Peissig PL; Trentham-Dietz A; Kitchner T; Fan J; Yuan M
    Acad Radiol; 2016 Jan; 23(1):62-9. PubMed ID: 26514439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
    Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Abbreviated Protocol for High-risk Screening Breast Magnetic Resonance Imaging: Impact on Performance Metrics and BI-RADS Assessment.
    Panigrahi B; Mullen L; Falomo E; Panigrahi B; Harvey S
    Acad Radiol; 2017 Sep; 24(9):1132-1138. PubMed ID: 28506511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
    Oztekin PS; Kosar PN
    Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
    McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
    Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective validation of a blood-based 9-miRNA profile for early detection of breast cancer in a cohort of women examined by clinical mammography.
    Lyng MB; Kodahl AR; Binder H; Ditzel HJ
    Mol Oncol; 2016 Dec; 10(10):1621-1626. PubMed ID: 27839676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of BI-RADS classification for breast imaging in women under age 50.
    Kennedy G; Markert M; Alexander JR; Avisar E
    Breast Cancer Res Treat; 2011 Dec; 130(3):819-23. PubMed ID: 21748292
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.